Table 3. Factors associated with renal dysfunction among HIV-infected children and HIV-uninfected siblings by univariable logistic regression.
With Renal Dysfunction | Without Renal Dysfunction | Odds Ratio (95% CI) | p-value | |
---|---|---|---|---|
(n = 112) | (n = 132) | |||
n (%) or median [IQR] | n (%) or median [IQR] | |||
Age (years) | 9 [5–11] | 8 [4.5–10] | 1.50 | 0.22 |
Sex | ||||
Male | 57 (50.89) | 61 (46.21) | 0.83 (0.51–1.37 | 0.47 |
Female | 55 (49.11) | 71 (53.79) | ||
Symptoms | ||||
Rash | 5 (4.46) | 13 (9.85) | 0.43 (0.15–1.24) | 0.12 |
Oral Sore | 1 (0.89) | 2 (1.52) | 0.59 (0.05–6.54) | 0.66 |
Diarrhea | 1 (0.89) | 1 (0.76) | 1.18 (0.07–19.09) | 0.91 |
Cough | 17 (15.18) | 21 (15.91) | 0.95 (0.47–1.90) | 0.88 |
Edema | 0 (-) | 0 (-) | - | - |
Past Medical History | ||||
Fever | 5 (4.46) | 9 (6.82) | 0.64 (0.21–1.96) | 0.43 |
TB | 8 (7.14) | 3 (2.27) | 3.30 (0.86–12.78) | 0.08 |
Herpes Zoster | 1 (0.89) | 3 (2.27) | 1.18 (0.07–19.09) | 0.91 |
Recurrent Pneumonia | 4 (3.57) | 2 (1.52) | 2.41 (0.43–13.40) | 0.32 |
Oral Thrush | 0 (-) | 3 (2.27) | - | - |
Co-trimoxazole use | 33 (29.46) | 33 (25.00) | 1.25 (0.71–2.21) | 0.43 |
Physical Examination | ||||
Pallor | 5 (4.5) | 7 (5.3) | 0.83 (0.26–2.71) | 0.76 |
Thrush | 1 (0.9) | 3 (2.3) | 0.39 (0.04–3.78) | 0.41 |
Lymphadenopathy | 16 (14.3) | 10 (7.6) | 2.03 (0.88–4.68) | 0.10 |
Severe Malnutrition | 1 (0.9) | 2 (1.5) | 0.59 (0.05–6.54) | 0.66 |
CD4 count (cells/uL)* | ||||
Mean | 535.8 (399.3) | 644.7 (363.4) | 1.58 | 0.11 |
Median | 481 [204–747] | 612 [341–895) | 0.82 | 0.37 |
WHO Clinical Stage* | ||||
1 | 0 (-) | 3 (4.9) | - | |
2 | 16 (26.7) | 23 (37.7) | 0.35 (0.09–1.35) | |
3 | 36 (60.0) | 31 (50.8) | 0.58 (0.16–2.12) | 0.23 |
4 | 8 (13.3) | 4 (6.6) | 1 | |
Random Blood Glucose | 6.2 [5.2–6.8] | 5.8 [5–6.7] | 2.25 | 0.13 |
Schistosoma positive † | 51 (45.5) | 33 (25.00) | 2.51 (1.46–4.31) | 0.001 |
Schistosoma intensity † | ||||
Negative | 61 (54.5) | 99 (75.0) | 1 | |
1+ | 12 (10.7) | 15 (11.4) | 1.30 (0.57–2.96) | |
2+ | 13 (11.6) | 5 (3.8) | 4.22 (1.43–12.4) | 0.001 |
3+ | 26 (23.2) | 13 (9.9) | 3.25 (1.55–6.79) | |
HIV-infected | 61 (54.5) | 61 (46.2) | 1.39 (0.84–2.31) | 0.19 |
*For the 122 HIV-infected cases only
† Schistosoma infection and intensity were both determined with the urine CAA assay.